Biosome, Inc.

Disease Prevention and Treatment

Charles F. Saller, Ph. D., the company's founder and CEO. Dr. Saller is also the founder and owner of ABS Inc. and is presently its President and CEO. He will relinquish most of his daily managerial responsibilities at ABS to focus on Biosomes operations. Dr. Saller is an inventor on the primary Biosomes® patent and several pending patents. Dr. Saller was the head biochemist on a team that discovered Seroquel, a highly successful antipsychotic drug. Prior to that, he was Pharmacology Research Associate at the National Institute of Health.

Raz Jelinek, Ph. D., Chief Scientific Officer. Prof. Jelinek, a faculty member and past Chair at the Department of Chemistry, Ben Gurion University, Israel, has been active during the past 10 years on development of Biosome-related sensing platforms. Prof. Jelinek has published over 40 scientific papers and the author of several pending patents on the technology.

Management Team